Skip to main content

Mary Vining Radomski

  • Mary Vining Radomski, PhD, OTR/L, FAOTA, senior scientific advisor, Courage Kenny Research Center

    Mary Vining RadomskiMary Vining Radomski is an occupational therapist and senior scientific advisor at the Courage Kenny Research Center. She has her doctorate in educational psychology (focus – learning and cognition) from the University of Minnesota and co-edits the widely-used textbook, Occupational Therapy for Physical Dysfunction with Dr. Catherine Trombly Latham.

    Dr. Radomski’s clinical work, research, and writing of the past two decades have centered on cognitive assessment and intervention for adults with mild cognitive impairment. These interests inform her two primary programs of research: cognitive assessment and treatment of soldiers with mild traumatic brain injury and assessment and treatment of people with cognitive dysfunction associated with treatment for cancer. Between 2009 – 2013, she was an ORISE Fellow with the Rehabilitation & Reintegration Division (Health Policy & Services, Army Medical Department - Office of the Surgeon General) and involved in supporting the development and implementation of evidence-based guidance for military occupational and physical therapists specific to soldiers with mild traumatic brain injury.

    Dr. Radomski currently has two studies funded by the Army Medical Research Materiel Command. She is co-principal investigator of an interdisciplinary, military-civilian research team that is developing a functional assessment to inform return to duty after concussion and principle investigator of a feasibility study to evaluate the impact of incorporating instruction in implementation intentions into cognitive rehabilitation intervention for soldiers with mild traumatic brain injury. In addition, she is conducting studies to evaluate the feasibility and preliminary outcomes of a brief psycho-educational intervention for “chemobrain” to examine the relationship between self-report and actual performance of women with cognitive issues associated with treatment for breast cancer.